US20200113930A1

US20200113930A1 - Methods And Compositions For Bowel Cleansing Before A Medical Procedure

Info

Publication number: US20200113930A1
Application number: US16/714,473
Authority: US
Inventors: Joshua Korzenik; Corey A. Siegel; Douglas Knuth
Original assignee: General Hospital Corp
Current assignee: General Hospital Corp
Priority date: 2008-07-09
Filing date: 2019-12-13
Publication date: 2020-04-16
Also published as: EP2309878A4; US9655919B2; EP2309878B1; US20110288180A1; SI2309878T1; PL2309878T3; LT2309878T; WO2010006209A2; HUE037424T2; WO2010006209A3; CA2736183C; EP2309878A2; AU2009268453C1; AU2009268453A1; PT2309878T; AU2009268453B2; ES2647813T3; CA2736183A1; HK1255405A1; AU2009268453B8

Abstract

Described are kits, food compositions and methods for cleaning the bowel, e.g., in preparation for a medical procedure, e.g., a diagnostic or treatment procedure, such as an endoscopic or surgical procedure, or radiologic imaging such as CT colography.

Description

CLAIM OF PRIORITY

This application is a continuation of U.S. patent application Ser. No. 15/854,535, filed Dec. 26, 2017, which is a continuation of U.S. patent application Ser. No. 15/085,363, filed Mar. 30, 2016, which is a continuation of U.S. patent application Ser. No. 13/002,887, filed on Aug. 10, 2011, now U.S. Pat. No. 9,655,919, which is a 371 application of PCT/US2009/050167, filed on Jul. 9, 2009, and claims the benefit of U.S. Provisional Patent Application Ser. No. 61/134,242, filed on Jul. 9, 2008, the entire contents of which are hereby incorporated by reference.

TECHNICAL FIELD

This invention relates to kits, food compositions and methods for cleaning the bowel, e.g., in preparation for a medical procedure, e.g., a diagnostic or treatment procedure, such as an endoscopic or surgical procedure, or radiologic imaging such as CT colography.

BACKGROUND

An estimated six million colonoscopies are performed annually in the United States, predominantly as a screening procedure to prevent colon cancer. Many patients report the most difficult aspect of the procedure is the preparation taken the day, night and morning before the procedure to evacuate stool and any other residue from the colon to allow for optimal visualization of the colon during the colonoscopic examination. The several existing options for cleaning the colon involve a variety of means providing a large amount of fluid (i.e., whole bowel irrigation), both orally ingested as well as induced through secretions of the small bowel, to wash out bowel contents.
A widely used whole bowel irrigation liquid formulation includes polyethelene glycol (PEG) in solution with electrolytes. These are non-absorbed solutions that require the ingestion of a substantial amount of fluid. These PEG lavage preparations (e.g., GOLYTELY, NULYTELY, and HALF-LYTELY from Braintree Laboratories Inc. (Braintree, Mass.), and the fruit flavored COLYTE from Schwarz Pharma, Inc. (Mequon, Wis.), which are usually taken by the patient at home the night or evening before the examination, cleanse the bowel through the induction of diarrhea. The osmotic activity of polyethylene glycol, in combination with the electrolyte concentration, results in virtually no net absorption or excretion of ions or water. Accordingly, large volumes can be administered without significant changes in fluid and electrolyte balance. Individuals undergoing these whole bowel irrigation preparations complain of nausea and often vomiting because of the need to take in a large amount of (unpleasant) tasting fluid and significant hunger. While most patients understand the need to clear the bowel completely prior to an endoscopic procedure—adequate preparation is key to an accurate colonoscopy—many balk at these unpleasant whole bowel irrigation preps.

SUMMARY

Described herein are a variety of prepared, low residue foods that contain a variety of laxatives as ingredients and incorporate an adequate amount of fluid so that an individual undergoing this preparation can continue to take in nutrition (unlike existing preps) while preparing for a procedure. In general, a large amount of distasteful fluid (whole bowel irrigation) would not be required. Different foods including appetizers, soups, main courses, desserts, snacks, and beverages are prepared with a variety of laxatives incorporated therein as ingredients so that the food itself is the delivery vehicle for the bowel cleanse. The food includes a variety of low residue foods, and can include foods with increasingly less residue as those taken closer to the procedure.
Thus, in one aspect, the invention provides kits for providing a therapeutic dietary regimen including a plurality of therapeutic foods for the preparation of a subject's bowel for a medical procedure. In general, the kits include enough food items for all of the meals to be ingested by the subject for a specified period prior to the medical procedure (e.g., the 24 hours before, the 48 hours before, the day before, or the day before and morning of, e.g., from 48 or 24 hours up to 2, 3, 4, 5, or 6 hours before). In some embodiments, the food items are low fiber, low residue foods, and some or all of the food items have incorporated therein an amount of a laxative agent sufficient to induce in the subject the production of watery yellow stools with a light yellow effluent. The kits and foods described herein are intended for use, and are effective for preparing the bowel, without the use of whole bowel irrigation.
In some embodiments, the kits also include all of the beverages to be consumed by the subject during the specified period. In some embodiments, the volume of all of the liquid foods and beverages to be consumed by the subject during the preparation period is less than about 2.5 liters, or less than 2 liters.
In some embodiments, the foods in the kit include a total of 0-6 g fiber. In some embodiments, the foods in the kit further include a total of 0.3-15 g Total Fats; 0-150 mg Cholesterol; 100-500 g of carbohydrates and 10-80 g of protein.
In some embodiments, the kits include solid foods (e.g., pasta, cookies, or bars) and liquid foods (e.g., soups, smoothies, and beverages).
In some embodiments, the medical procedure is selected from the group consisting of colonoscopy, intestinal surgery, virtual colography, and barium studies.
In another aspect, the invention provides methods for preparing a subject's bowel for a medical procedure, e.g., for assisting a subject in preparing their bowel, the method including providing to (e.g., administering to, or prescribing for, or providing instructions regarding) the subject a therapeutic dietary regimen including a plurality of therapeutic foods, i.e., a dietary regimen that includes all the meals that are to be ingested by the subject for a specified period prior to the medical procedure (e.g., the 24 hours before, the 48 hours before, the day before, or the day before and morning of, e.g., from 48 or 24 hours up to 2, 3, 4, 5, or 6 hours before). In some embodiments, the food items are low fiber, low residue foods, and some or all of the food items have incorporated therein an amount of a laxative agent sufficient to induce in the subject the production of watery yellow stools with a light yellow effluent. The methods described herein are intended for use, and are effective for preparing the bowel, without the use of whole bowel irrigation.
In some embodiments, all of the beverages to be consumed by the subject during the specified period are also provided or specified, and some or all of the beverages also include a laxative agent. In some embodiments, the volume of all of the liquid foods and beverages to be consumed by the subject during the preparation period is less than about 2.5 liters, or less than 2 liters.
In some embodiments, the foods (and optionally beverages) include a total of 0-6 g fiber. In some embodiments, the foods (and optionally beverages) further include a total of 0.3-15 g Total Fats; 0-150 mg Cholesterol; 100-500 g of carbohydrates and 10-80 g of protein.
In some embodiments, the methods include providing solid foods and liquid foods.
In some embodiments, the methods include administering very low- or no-residue foods to be consumed up to two hours prior to the procedure, e.g., to be consumed between 6 (e.g., 12, 11, 10, 9, 8, 7) hours and 2 hours before the procedure.
Also described herein is the use of the kits and foods described herein in a method (described herein) of preparing a subject's bowel for a medical procedure.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Methods and materials are described herein for use in the present invention; other, suitable methods and materials known in the art can also be used. The materials, methods, and examples are illustrative only and not intended to be limiting. All publications, patent applications, patents, sequences, database entries, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control.
Other features and advantages of the invention will be apparent from the following detailed description and figures, and from the claims.

DESCRIPTION OF DRAWINGS

FIGS. 1A-B show a sample selectable menu and instructions for use.

FIGS. 2A-2D show exemplary menus for subjects on normal diets (2A), pediatric diets (2B), diabetic diets (2C), and renal diets (2D).

FIGS. 3A-3D show restrictions on the food types for subjects with special diets, e.g., pediatric, diabetic, liver (i.e., for subjects with compromised liver function), gluten free, vegetarian, Kosher and renal (i.e., for subjects with compromised kidney function) diets. X indicates a food that is available for selection for that category of subject.

DETAILED DESCRIPTION

Millions of Americans undergo bowel preparations annually, to prepare for colonoscopies, intestinal surgery (e.g., polypectomy, resection, colostomy, or ileostomy), virtual colography, and barium studies (e.g., using a barium enema). These preps are usually performed using a liquid preparation for whole bowel irrigation; although phospha soda formulations in pill form are available, their use has been restricted due to possible renal injury.
Current recommendations for an appropriate diet before colonoscopy restrict diet to clear liquids and/or a low residue foods for 1-4 days prior to initiating the bowel cleansing product (see Hawes et al., Gastrointestinal Endoscopy 63 (7):894-909 (2006)). Current preparation regimes indicate that any intake of solids or liquids other than what is part of the prep must be stopped prior to initiating the prep. For example, one commercially-available diet, NUTRA-PREP™ (E-Z-EM, Lake Success, N.Y.), formalizes some of these practices in a prepackaged set of meals to be taken prior to beginning a prep. As described in U.S. Pat. No. 6,866,873 (with which the NUTRA-PREP is marked), clinical tests (see, e.g., Delegge and Kaplan, Aliment Pharmacol Ther 21:1491-1495 (2005)), and the patient instructions, the NUTRA-PREP diet is to be taken prior to initiating any of the bowel prep products with a minimum specified time interval between completing the final intake of food and beginning the bowel cleansing product. U.S. Pat. No. 6,866,873 teaches that the meals are to be utilized prior to the use of any bowel cleansing products, which are to then used as indicated. While these bowel cleansing products differ in content and amount of water to be taken along with them, the instructions for each prep is to complete intake of food or liquids (other than the water which is part of some preps) prior to initiating the product. As described in Delegge and Kaplan, Aliment Pharmacol Ther 21:1491-1495 (2005), patients in a clinical study of the effectiveness of the NUTRA-PREP regime consumed the NUTRA-PREP food prior to initiation of the LOSO prep, which was begun at 4 PM the day before the colonoscopy, thus requiring a fast of longer than 12 hours for most patients.
In contrast, the methods and composition described herein differ from existing preps (including NUTRA-PREP), at least in that food is used as the delivery vehicle for the prep, so that an individual continues dietary intake, e.g., provided in a prepared diet, in order to deliver the bowel cleansing product efficiently and effectively to perform the prep. This concept runs contrary to existing art, established practice and expert opinion of how a colon can be prepared for a colonoscopy, gastrointestinal surgery or virtual (CT) colography. By utilizing food to deliver the prep, the present methods are contradictory in theory and practice to currently accepted methods, which as noted above require that the individual cease taking in food or liquids (other than those required by the prep) in order to sufficiently cleanse the colon. The methods described herein provide an adequate cleansing and do not require that dietary intake be discontinued prior to initiating a prep, and therefore do not require a prolonged fast; this will encourage and assist with complete ingestion of the prep (as many patients have difficulty with existing preps due to unpalatable taste, “taste fatigue,” and side effects like nausea and fasting) and will enhance the cleansing of the colon. As most patients find the most difficult part of the colonoscopy experience is the prep and not the procedure itself, the approach described herein will improve the quality of the experience significantly by enhancing acceptability of the prep, decreasing side effects (dizziness, dehydration, nausea, vomiting, taste fatigue, etc) and thereby provide a better prep for the colon. This approach may also reduce healthcare costs by increasing the percentage of adequately prepped colons and reducing the wasted resources related to the need to cancel and repeat colonoscopies for inadequately prepped patients.
Thus, described herein are therapeutic food compositions that include low-residue foods with cleansing agents incorporated therein, for use in the preparation of the bowel for procedures including colonoscopy, intestinal surgery, virtual colography, and barium studies (barium enema), inter alia, and methods of use thereof.

Low-Residue Foods

As used herein, the term “food” or “foods” includes both solid and liquid forms of food, including beverages. As used herein, a low residue diet typically contains less than about 5 or 6 grams of fiber per day, and generally limits foods that leave significant amounts of fecal residue in the colon. Low residue foods are those that leave little or no residue in the bowel, and can include white bread, refined pasta and cereals, and white rice; some canned or well-cooked fruits or vegetables that do not include skins, peels or seeds; tender, ground, and well cooked meat, fish, eggs, and poultry; less than 2 cups per day of milk and yogurt; mild cheeses, such as ricotta and cottage cheese; butter, mayonnaise, vegetable oils, margarine, plain gravies and dressings; broth and strained soups from allowed foods; and pulp free, strained, or clear juices. In some embodiments, the foods useful in the methods and compositions described herein should:

- 1. Omit raw, high fiber vegetables and fruits
- 2. Omit whole grains, seeds, nuts and skins
- 3. Omit high fats foods that slow gastric emptying
- 4. Fiber content per serving should be 1 gram or less, for a total of less than about 5 or 6 grams per day
- 5. Dairy intake is limited to 2 cups per day, including puddings and strained cream soups.
  Table 1 provides an exemplary listing of foods allowed and excluded from a low fiber/low residue diet. One of skill in the art will readily be able to identify other foods that can be used, and those that should be avoided.

TABLE 1

Low Fiber/Residue Diet

Food Group	Allowed	Excluded

Starch	Cereals, rice, pasta, and	Whole grain cereals, rice,
	other products made with	pasta, legumes, and
	refined grains	popcorn
Vegetables	Strained vegetable juices,	All vegetables
	Potatoes without skins
Fruits	Fruit juices except prune	All fruits including canned
Dairy	Limited to 2 cups per day	Whole milk/cream or
	including yogurts,	foods made with them;
	smoothies, puddings and	cheese
	strained cream soups
Meats/Meat	Eggs, fish, (tofu)	Beef, pork, chicken,
Substitutes		processed meats, dried
		peas/beans, peanut butter
Desserts	Gelatin, pudding, sherbet,	All pastries plus desserts
	sorbet, custards, plain cake	that contain skins, nuts,
	(angel food), plain cookies	seeds and raisins
	(sugar), yogurt, smoothies
Beverages	Coffee and tea (limited),
	non-cola sodas, pulp free
	fruit juices, pulp free fruit
	ice white ice tea, non-
	caloric teas and beverages,
	freezer pops, milk (limited
	intake), smoothies, protein
	drinks
Miscellaneous		Nuts, seeds

In addition, the foods useful in the kits, compositions and methods described herein are low in fat (i.e., less than 15 grams of fat per day or prep period) and bland colored (e.g., white, cream, yellow, or clear) to allow for adequate colon cleansing.
The general nutritional value of a 24 hour regimen of the foods described herein is set forth in Table 2.

TABLE 2

Nutritional Value

Calories	1000-2500
From Carbohydrate	400-2000
From Fat	5-200
From Protein	80-320
Total Carbohydrate	100-500	g
Dietary Fiber	0-6	g
Protein	10-80	g
Total Fats	0.3-15	g
Cholesterol	0-150	mg

The foods can be in forms that include, but are not limited to, soups (broths, chicken noodle soup), juices, teas, milk, pancakes with syrup, low-fat muffins, yogurt smoothies, pasta with sauce, puddings, and custards. A number of sample recipes are provided herein, see below.
FIGS. 2A-3D show exemplary (non-limiting) menus for subjects on normal diets (2A), pediatric diets (2B), diabetic diets (2C), and renal diets (2D). FIGS. 3A-3D show exemplary (non-limiting) food restrictions for subjects with special diets, e.g., pediatric, diabetic, liver (i.e., for subjects with compromised liver function), gluten free, vegetarian, Kosher and renal (i.e., for subjects with compromised kidney function) diets.

Laxative Agents

Rather than relying on one agent as is done at present in essentially all existing preparations, the present methods can utilize a variety of agents including, but not limited to, hydrating agents (osmotics), e.g., dibasic sodium phosphate, magnesium citrate, magnesium hydroxide (milk of magnesia), magnesium sulfate (Epsom salt), monobasic sodium phosphate, sodium biphosphate, lactulose, polyethylene glycol (PEG), e.g., PEG 3350, vitamin C, and sorbitol. Other laxative agents are known in the art, e.g., those described in Delegge and Kaplan, Aliment Pharmacol Ther 21:1491-1495 (2005).
In some embodiments, the laxative agent is not a senna laxative, e.g., is not an anthraquinone derivative (e.g., not a glycoside or sennoside).
The dose of the laxative provided in each meal should be an amount sufficient to induce the presence of watery yellow stools with light yellow or clear effluent within about 6-8 hours of the initiation of the prep; this effluent is a clinical indicator of an adequate cleansing of the colon and is used as a clinical guide and surrogate marker for an adequate colon cleansing to permit a thorough inspection of the lining of the colon.
Exemplary doses of the laxative agents are as follows:


magnesium citrate	0-20	oz
PEG 3350	0-255	gms
milk of magnesia	0-120	ml
magnesium sulfate	0-2	tablespoons

lactulose

0-120 ml (0-90 gms)

vitamin C

0-40

gms

	sorbitol	0-100 ml of 70% solution

Since combinations of the agents can be used, one of skill in the art will be able to determine an appropriate dose. In one example, if only PEG 3350 is used, a dose of about 255 g per day can be used; if only sorbitol is used, about 100 ml per day of a 70% solution can be used. As a further example, if a combination of the two is used, e.g., 50% PEG 3350 and 50% sorbitol, then the doses given above can be altered correspondingly.

Methods of Preparation

The foods described herein can be made using standard cooking methods known in the art, including processing, mixing, precooking, cooking (including baking, steaming, and frying, inter alia), freezing, dehydrating or freeze-drying. The laxative agents can be incorporated therein by any method including mixing in as an ingredient e.g., as in a baked good, or by inclusion as a topping, sauce, or glaze, e.g., as in a sauce for pasta or a protein source such as meat or tofu.
In some embodiments, a kit is provided that includes all of the meals required for a subject to complete the preparation for the procedure, e.g., all of the meals that the subject will consume the day before the procedure. In some embodiments, the kit also include all of the beverages that the subject will consume. The kit can also include instructions for use in a method described herein.
In some embodiments, the foods are provided in prepackaged form, e.g., packed in a container, e.g., in a shelf stable, refrigerated, or frozen form. The kits can be purchased, e.g., from a pharmacy or other retail outlet.
Additionally, the food can be prepared and packaged such that some or all of the food items require some (preferably simple) preparation by the subject, e.g., mixing (e.g., by hand or in a blender or food processor), cooking (e.g., on a stove top, in an oven or microwave), or diluting, e.g., by adding cool, hot or boiling water, or by submerging the food item into boiling water. Alternatively, some or all of the foods can be provided to the subject in ready-to-eat form, e.g., as a bar or canned liquid (e.g., a beverage).
In some embodiments, the foods are prepared to order once the subject has made menu selections. The foods can be prepared, e.g., by a health care institution such as a clinic or inpatient facility, or by a specialized producer of such foods. The foods can then be delivered to the subject, e.g., at home or in a facility, or picked up by the patient.

Methods of Use

The foods described herein are intended for consumption by subjects preceding a procedure that requires a clean bowel, i.e., a medical procedure such as a surgical or diagnostic procedure, to prepare the bowel for the procedure. Such procedures include colonoscopy, intestinal surgery, virtual colography, fiberoptic endoscopy, sigmoidoscopy, wireless capsule endoscopy (WCE) (which uses a miniaturized scope administered in a “pill” form) and barium studies (barium enema), inter alia.
In some embodiments, patients are given a menu from which they can make a certain number of choices among several different groups of foods in order to take in adequate amounts of laxatives and fluid to provide an adequate bowel preparation (see an example menu set forth in FIGS. 1A-1B). These instructions can be provided directly by their health care provider, or can be provided to the patient, e.g., via a pamphlet, package insert or internet web page. Once selections are made, the foods can be, e.g., obtained from a supplier, or delivered to the patient's home for consumption.
In some embodiments, the methods of treatment will include the ingestion of these foods starting at 72, 48, 36, 24, or 12 hours prior to a scheduled procedure; these foods can be consumed up to a few hours prior to the procedure, e.g., up to about 2, 3, 4, 5, or 6 hours prior to the procedure. The administration regimen can include the ingestion of foods with increasingly less residue closer to the procedure. For example, the meals consumed closer to the procedure can contain substantially no fiber (i.e., less than 1 g fiber) and no dairy products.
In general, the methods described herein do not include the use of a high-volume liquid prep as is known in the art (described above) for whole bowel irrigation. An enema, e.g., a tap water enema, may be used in some cases.

Sample Recipes

Although the following recipes specify MIRALAX™ (PEG 3350) or sorbitol, one of skill in the art will appreciate that equally effective amounts of other laxatives can also be used.

Raspberry Yogurt Muffins

23 grams of flour
5.5 grams sugar
0.4 grams baking soda
100 micrograms salt
5 milliliters orange juice
2.5 milliliters vegetable oil
0.2 milliliters almost extract
20 milliliters nonfat vanilla yogurt
4 grams liquid egg substitute
1 milliliter raspberry extract
17 grams MIRALAX
--

Directions:

Line a muffin tin with paper liners
Preheat oven to 400° F.
In large bowl combine flour, sugar, baking powder, baking soda, salt and MIRALAX.
Mix well.
In another bowl, whisk together orange juice, oil extracts, yogurt and egg. Add to dry ingredients and stir until moistened. Spoon into muffin liners.
Bake at 400 F for 20 minutes.
Yogurt Smoothie (orange-banana)
240 milliliters pulp free orange juice
240 milliliters of non-fat yogurt
0.5 grams of cinnamon
118 grams of ripe banana (1 medium)
17 grams MIRALAX
--

Directions:

Place all ingredients into blender, process until smooth.

Orange-Pineapple Popsicle

60 milliliters pulp free orange juice
60 milliliters pineapple juice
17 grams MIRALAX
--

Directions:

Mix and freeze in a popsicle mold.

Coconut Pudding 1

120 milliliters coconut milk
12.5 grams of sugar
8 grams of cornstarch
100 micrograms of salt
0.5 grams of cinnamon
17 grams MIRALAX
--

Directions:

In a saucepan, mix together cornstarch, salt, sugar, and MIRALAX. Whisk in coconut milk and simmer over medium heat. Stir constantly until mixture thickens. Pour into serving dishes and chill at least 1 hour. Optionally, garnish with cinnamon powder.

Coconut Pudding 2

236 grams coconut milk
28 grams of arrowroot
up to 30 ml of 70% sorbitol solution
--
Prepare as directed above for Coconut Pudding 1.

Cream of Rice Cereal

244 grams of cereal cooked with water without salt
112 gram of skim milk
up to 30 ml of 70% sorbitol solution
--
Mix cereal, rice and sorbitol together with water; heat and serve

EXAMPLE

The invention is further described in the following example, which does not limit the scope of the invention described in the claims.

Example 1

A pilot test was conducted with three subjects. Patients 1, 2 and 3 consumed the contents of a full menu designed for colon preparation. Items included in the menu are listed in Table 3. Results were uniform across all three subjects. Within 2-3 hrs of the beginning of the preparation all subjects had an urgency to move their bowels. Within 4-5 hours of beginning the preparation the subjects all had a significant volume of watery diarrhea. By 6 hours after initiation of the preparation, the subjects all had watery yellow stools with an effluent appearance similar to what we expect at the time of colonoscopy. This light yellow effluent is a clinical indicator of an adequate cleansing of the colon and is used as a clinical guide and surrogate marker for an adequate colon cleansing to permit a thorough inspection of the lining of the colon.
Other than the diarrhea, effects included gas and mild abdominal cramping. No other side-effects were noted. All subjects noted that the food was good tasting, they were not hungry during the preparation, they did not experience taste fatigue, nausea or significant abdominal bloating.

TABLE 3

Study Meals

Breakfast	Snacks	Lunch	Dinner	Drinks

Pancakes w/syrup	Fruit	Potato leek	Asian	Apple
	smoothie	soup	noodles	juice
Blueberry muffin	Vanilla	Asian	Frozen	Lemonade
	Pudding	noodles	pop
Toasted rice	Pretzels	Creamy garlic	Vegetable	Raspberry
cereal with soy	with honey	sauce with	soup	iced tea
milk	mustard	noodles
SMOOTH	Frozen	Tortellini	Fruit	White
MOVE^R	pop	with alfredo	smoothie	cranberry
senna leaf tea		sauce		juice
(Traditional
Medicinals,
Sebastopol, CA)

Other Embodiments

It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.

Claims

What is claimed is:

1. A kit for providing a therapeutic dietary regimen comprising a plurality of therapeutic foods for the preparation of a subject's bowel for a medical procedure, wherein the kit comprises food items sufficient for all of the meals to be ingested by the subject for a specified period prior to the medical procedure, and wherein the food items are low fiber, low residue foods, and further wherein the food items have incorporated therein an amount of a laxative agent sufficient to induce in the subject the production of watery yellow stools with a light yellow effluent.